e.g. Tata motors, Reliance MF, 500570

Jubilant Pharmova Ltd. - Research Center

530019 JUBLPHARMA Group (A) BSE data
 
Back to Company Page
Statement:

Profit loss account

(Rs crore)
Mar ' 25 Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21
Income
Operating income 745.70 784.70 810.12 87.75 2,709.50
Expenses
Material consumed 295.10 378.30 414.55 - 1,564.02
Manufacturing expenses 78.00 68.40 75.37 9.27 280.40
Personnel expenses 203.00 190.00 167.27 49.21 220.67
Selling expenses 3.80 3.00 1.43 0.33 0.26
Adminstrative expenses 133.70 128.50 148.26 35.72 217.08
Expenses capitalised - - - - -
Cost of sales 713.60 768.20 806.89 94.54 2,282.44
Operating profit 32.10 16.50 3.23 -6.79 427.06
Other recurring income 99.60 103.40 137.89 125.87 47.88
Adjusted PBDIT 131.70 119.90 141.12 119.08 474.94
Financial expenses 29.80 29.90 18.52 30.59 101.80
Depreciation 53.10 48.30 43.25 6.25 99.97
Other write offs - - - - -
Adjusted PBT 48.80 41.70 79.34 82.25 273.17
Tax charges 18.40 10.10 29.46 3.75 58.69
Adjusted PAT 30.40 31.60 49.88 78.50 214.48
Non recurring items -11.50 -0.20 -0.77 0.25 -0.71
Other non cash adjustments - - - - -
Reported net profit 18.90 31.40 49.11 78.75 213.77
Earnigs before appropriation 1,094.50 1,155.00 1,203.14 1,233.67 1,367.03
Equity dividend 79.60 79.60 79.64 79.64 -
Preference dividend - - - - -
Dividend tax - - - - -
Retained earnings 1,014.90 1,075.40 1,123.50 1,154.03 1,367.03
Close
Add Jubilant Pharmova Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Jubilant Pharmova Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback